Environ Toxicol Pharmacol. 1996 Jul 15;1(4):227-33. doi: 10.1016/1382-6689(96)00012-9.
To investigate the mechanism of the airway narrowing induced by cigarette smoke, anaesthetized guinea pigs were exposed to 200 puffs of smoke for 10 min. Airway narrowing was assessed by monitoring the total pulmonary resistance (R(L)). Plasma extravasation was determined by measuring the amount of Evans blue dye extravasated into the trachea and main bronchi. Exposure to cigarette smoke caused a marked airway narrowing and plasma extravasation. Pretreatment with the dual NK(1) and NK(2) receptor antagonist, FK224, abolished such airway narrowing and significantly inhibited the extravasation. While the NK(1) receptor antagonist, FK888, inhibited the extravasation, it had no effect on airway narrowing. Atropine partially inhibited airway narrowing without affecting extravasation. Results suggest that the airway narrowing induced by cigarette smoke is caused by tachykinins, and that a cholinergic pathway is involved. Thickening of the airway walls induced by NK(1) receptor-mediated extravasation may not be involved in such airway narrowing.
为了研究香烟烟雾引起气道狭窄的机制,给麻醉的豚鼠吸入 200 口香烟烟雾,每次 10 分钟。通过监测总肺阻力(R(L))来评估气道狭窄。通过测量埃文斯蓝染料渗出到气管和主支气管的量来确定血浆渗出。暴露于香烟烟雾会导致明显的气道狭窄和血浆渗出。用双重 NK(1)和 NK(2)受体拮抗剂 FK224 预处理可消除这种气道狭窄,并显著抑制渗出。虽然 NK(1)受体拮抗剂 FK888 抑制渗出,但对气道狭窄没有影响。阿托品部分抑制气道狭窄,而不影响渗出。结果表明,香烟烟雾引起的气道狭窄是由速激肽引起的,涉及胆碱能途径。NK(1)受体介导的渗出引起的气道壁增厚可能不参与这种气道狭窄。